The primary goal of titration is to reduce the severity of gastrointestinal side effects, such as nausea, vomiting, bloating, or diarrhea, which are most common when you start treatment or increase the dosage
"Patients are in a precarious situation right now," Noorian said
Match monotherapy to monotherapy
These results rivaled those achieved through bariatric surgery, although Retatrutide is still not accessible for public use as it awaits FDA approval
Discontinuation rates within the first year are consistently reported between approximately 45 and 75% (Sikirica et al., 2017
Kras LSL-G12D/+ ;Trp53 LSL-R172H/+ ;Pdx1-Cre;Rosa26 YFP/YFP (KPCY) cancer cells 30 were injected when RETA/SEMA weight loss plateaued after 2 weeks (Fig